HLN
Haleon plcNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$41.15B
P/E Ratio
18.58
EPS
$0.50
Beta
0.25
52W High
$11.20
52W Low
$8.60
50-Day MA
$9.61
200-Day MA
$9.77
Dividend Yield
0.76%
Profit Margin
15.10%
Forward P/E
17.30
PEG Ratio
2.44
About Haleon plc
Haleon plc (HLN) is a leading global consumer health company, formed as a spin-off from GlaxoSmithKline, that specializes in delivering innovative health solutions through its extensive portfolio of trusted brands, including Sensodyne, Panadol, and Voltaren. With a focus on key health segments such as oral care, pain relief, and dietary supplements, Haleon leverages strong brand recognition to meet the evolving needs of consumers. The company's commitment to sustainability and continuous innovation positions it strategically for long-term growth, aimed at enhancing health outcomes and delivering shareholder value through targeted investments and ongoing product development.
Fundamentals
| Revenue (TTM) | $11.03B |
| Gross Profit (TTM) | $7.14B |
| EBITDA | $2.74B |
| Operating Margin | 23.20% |
| Return on Equity | 10.30% |
| Return on Assets | 4.67% |
| Revenue/Share (TTM) | $2.46 |
| Book Value | $4.96 |
| Price-to-Book | 1.86 |
| Price-to-Sales (TTM) | 3.73 |
| EV/Revenue | 3.425 |
| EV/EBITDA | 13.21 |
| Quarterly Earnings Growth (YoY) | 92.00% |
| Quarterly Revenue Growth (YoY) | 0.60% |
| Shares Outstanding | $4.43B |
| Float | $8.86B |
| % Insiders | 0.01% |
| % Institutions | 13.20% |
Historical Volatility
HV 10-Day
18.75%
HV 20-Day
19.08%
HV 30-Day
19.05%
HV 60-Day
21.58%
HV Rank
27.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($11.74 target)
2
Strong Buy1
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026